Legal Representation
Attorney
Christina M. Licursi
Application History
3 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 18, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 18, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 18, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity
Class 010
Medical tools being devices for diagnosing erythropoietic protoporphyria; medical tools being devices for treating and diagnosing sun exposure
Class 042
(Based on Use) research and development of pharmaceuticals and biologics for the treatment of immunologic disorders, hematologic disorders, anemia disorders, oncologic disorders and renal disorders; none of the foregoing offered in connection with treatment of diseases or disorders relating to spinal discs (Based on Intent to Use) Scientific research and development in the field of sun exposure and related disease risk; research and development of pharmaceuticals, biologic preparations and medicines in the field of sun exposure and related disease risk; medical research and development in the field of sun exposure and related disease risk; conducting surveys and questionnaires being surveys to detect sun exposure and related disease risk
First Use Anywhere:
20190600
First Use in Commerce:
Oct 29, 2019
Classification
International Classes
005
010
042